Infect Immun. 1993 January; 61(1): 245-252
Characterization of macrophage sensitivity and resistance to anthrax lethal toxin.
A M Friedlander,
R Bhatnagar,
S H Leppla,
L Johnson and
Y Singh
U.S. Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702-5011.
ABSTRACT
Anthrax lethal toxin, which consists of two proteins, protective antigen and lethal factor, is cytolytic for macrophages. Macrophages from different mouse strains were found to vary in their sensitivities to toxin. C3H mouse macrophages lysed by lethal factor concentrations of 0.001 micrograms/ml were 100,000 times more sensitive than those from resistant A/J mice. We analyzed various stages of the intoxication process to determine the basis for this resistance. Direct binding studies with radioiodinated protective antigen revealed that the affinity (Kd, approximately 0.5 nM) and number of receptors per cell (25,000 to 33,000) were the same in sensitive and resistant cells. Proteolytic activation of protective antigen by a cell surface protease and subsequent binding of lethal factor were also the same in both sensitive and resistant macrophages. Resistant A/J macrophages were not cross-resistant to other toxins and a virus which, like lethal toxin, require vesicular acidification for activity, implying that resistance is not due to a defect in vesicular acidification. When introduced into the cytosol by osmotic lysis of pinosomes, lethal factor in the absence of protective antigen was cytolytic for the sensitive macrophages while resistant cells were unaffected. Thus, lethal factor by itself possesses the toxic activity of lethal toxin. These results suggest that macrophage resistance is due to a defect at a stage occurring after toxin internalization. A/J macrophages may lack the putative lethal factor target in the cytosol or be defective in the further processing or activation of lethal factor in the cytosol or in endocytic vesicles.
Infect Immun. 1993 January; 61(1): 245-252
This article has been cited by other articles:
-
Omland, K. S., Brys, A., Lansky, D., Clement, K., Lynn, F., and the Participating Laboratories,
(2008). Interlaboratory Comparison of Results of an Anthrax Lethal Toxin Neutralization Assay for Assessment of Functional Antibodies in Multiple Species. CVI
15: 946-953
[Abstract]
[Full Text]
-
Scorpio, A., Tobery, S. A., Ribot, W. J., Friedlander, A. M.
(2008). Treatment of Experimental Anthrax with Recombinant Capsule Depolymerase. Antimicrob. Agents Chemother.
52: 1014-1020
[Abstract]
[Full Text]
-
Squires, R. C., Muehlbauer, S. M., Brojatsch, J.
(2007). Proteasomes Control Caspase-1 Activation in Anthrax Lethal Toxin-mediated Cell Killing. J. Biol. Chem.
282: 34260-34267
[Abstract]
[Full Text]
-
Moayeri, M., Wiggins, J. F., Lindeman, R. E., Leppla, S. H.
(2006). Cisplatin inhibition of anthrax lethal toxin.. Antimicrob. Agents Chemother.
50: 2658-2665
[Abstract]
[Full Text]
-
Stearns-Kurosawa, D. J., Lupu, F., Taylor, F. B. Jr., Kinasewitz, G., Kurosawa, S.
(2006). Sepsis and Pathophysiology of Anthrax in a Nonhuman Primate Model. Am. J. Pathol.
169: 433-444
[Abstract]
[Full Text]
-
Moayeri, M., Wickliffe, K. E., Wiggins, J. F., Leppla, S. H.
(2006). Oxidized ATP Protection against Anthrax Lethal Toxin. Infect. Immun.
74: 3707-3714
[Abstract]
[Full Text]
-
Crawford, M. A., Aylott, C. V., Bourdeau, R. W., Bokoch, G. M.
(2006). Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity.. J. Immunol.
176: 7557-7565
[Abstract]
[Full Text]
-
McConnell, M. J., Hanna, P. C., Imperiale, M. J.
(2006). Cytokine Response and Survival of Mice Immunized with an Adenovirus Expressing Bacillus anthracis Protective Antigen Domain 4. Infect. Immun.
74: 1009-1015
[Abstract]
[Full Text]
-
Duverger, A., Jackson, R. J., van Ginkel, F. W., Fischer, R., Tafaro, A., Leppla, S. H., Fujihashi, K., Kiyono, H., McGhee, J. R., Boyaka, P. N.
(2006). Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens. J. Immunol.
176: 1776-1783
[Abstract]
[Full Text]
-
Rainey, G. J. A., Wigelsworth, D. J., Ryan, P. L., Scobie, H. M., Collier, R. J., Young, J. A. T.
(2005). Receptor-specific requirements for anthrax toxin delivery into cells. Proc. Natl. Acad. Sci. USA
102: 13278-13283
[Abstract]
[Full Text]
-
Komiyama, T., Swanson, J. A., Fuller, R. S.
(2005). Protection from Anthrax Toxin-Mediated Killing of Macrophages by the Combined Effects of Furin Inhibitors and Chloroquine. Antimicrob. Agents Chemother.
49: 3875-3882
[Abstract]
[Full Text]
-
Moayeri, M., Webster, J. I., Wiggins, J. F., Leppla, S. H., Sternberg, E. M.
(2005). Endocrine Perturbation Increases Susceptibility of Mice to Anthrax Lethal Toxin. Infect. Immun.
73: 4238-4244
[Abstract]
[Full Text]
-
Tournier, J.-N., Quesnel-Hellmann, A., Mathieu, J., Montecucco, C., Tang, W.-J., Mock, M., Vidal, D. R., Goossens, P. L.
(2005). Anthrax Edema Toxin Cooperates with Lethal Toxin to Impair Cytokine Secretion during Infection of Dendritic Cells. J. Immunol.
174: 4934-4941
[Abstract]
[Full Text]
-
Comer, J. E., Galindo, C. L., Chopra, A. K., Peterson, J. W.
(2005). GeneChip Analyses of Global Transcriptional Responses of Murine Macrophages to the Lethal Toxin of Bacillus anthracis. Infect. Immun.
73: 1879-1885
[Abstract]
[Full Text]
-
Mohamed, N., Clagett, M., Li, J., Jones, S., Pincus, S., D'Alia, G., Nardone, L., Babin, M., Spitalny, G., Casey, L.
(2005). A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge. Infect. Immun.
73: 795-802
[Abstract]
[Full Text]
-
Moayeri, M., Martinez, N. W., Wiggins, J., Young, H. A., Leppla, S. H.
(2004). Mouse Susceptibility to Anthrax Lethal Toxin Is Influenced by Genetic Factors in Addition to Those Controlling Macrophage Sensitivity. Infect. Immun.
72: 4439-4447
[Abstract]
[Full Text]
-
Gimenez, A. P., Wu, Y.-Z., Paya, M., Delclaux, C., Touqui, L., Goossens, P. L.
(2004). High Bactericidal Efficiency of Type IIA Phospholipase A2 against Bacillus anthracis and Inhibition of Its Secretion by the Lethal Toxin. J. Immunol.
173: 521-530
[Abstract]
[Full Text]
-
WEBSTER, J. I., MOAYERI, M., STERNBERG, E. M.
(2004). Novel Repression of the Glucocorticoid Receptor by Anthrax Lethal Toxin. Ann. N. Y. Acad. Sci.
1024: 9-23
[Abstract]
[Full Text]
-
McAllister, R. D., Singh, Y., du Bois, W. D., Potter, M., Boehm, T., Meeker, N. D., Fillmore, P. D., Anderson, L. M., Poynter, M. E., Teuscher, C.
(2003). Susceptibility to Anthrax Lethal Toxin Is Controlled by Three Linked Quantitative Trait Loci. Am. J. Pathol.
163: 1735-1741
[Abstract]
[Full Text]
-
Kumar, P., Ahuja, N., Bhatnagar, R.
(2001). Purification of Anthrax Edema Factor from Escherichia coli and Identification of Residues Required for Binding to Anthrax Protective Antigen. Infect. Immun.
69: 6532-6536
[Abstract]
[Full Text]
-
Fouet, A., Namy, O., Lambert, G.
(2000). Characterization of the Operon Encoding the Alternative sigma B Factor from Bacillus anthracis and Its Role in Virulence. J. Bacteriol.
182: 5036-5045
[Abstract]
[Full Text]
-
Gupta, P., Batra, S., Chopra, A. P., Singh, Y., Bhatnagar, R.
(1998). Expression and Purification of the Recombinant Lethal Factor of Bacillus anthracis. Infect. Immun.
66: 862-865
[Abstract]
[Full Text]
Copyright © 1993 by the American Society for Microbiology. All rights reserved.